03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Arava 100mg* : | |
Type | Medicine Non Marketed |
Originator | B |
Agent | Mersaco |
Distributor | Mersaco |
Laboratory | Sanofi |
Responsible Party | Sanofi Aventis Deutschland GmbH |
Origin | Germany |
Manufacturer | Sanofi Winthrop Industrie |
Origin | France |
ATC | L04AA13 |
Revision Date | 25/092014 |
Arava 100mg* :
Arava 100mg* :
Arava 100mg* :
Arava 100mg* :
Arava 100mg* :
Hazard Level |
---|
◼ Major |
◼ Moderate |
◼ Minor |
◼ Safe |
Arava 100mg* :
Arava 100mg* :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Abdominal pain | Common |
Accelerated hair loss | Common |
Agranulocytosis | Very rare |
Allergic reaction | Common |
ALT increased | Common |
Anaemia | Uncommon |
Anaphylactic reactions | Very rare |
Anaphylactoid reactions | Very rare |
Anorexia | Common |
Anxiety | Uncommon |
Aphthous stomatitis | Common |
Asthenia | Common |
Blood alkaline phosphatase increased | Common |
Blood bilirubin increased | Common |
Blood creatine phosphokinase increased | Common |
Blood lactate dehydrogenase increased | Rare |
Blood pressure increased | Common |
Bronchitis | Not known |
Cholestasis | Rare |
Cutaneous lupus erythematosus | Not known |
Diarrhoea (Diarrhea) | Common |
Dizziness | Common |
DRESS (Drug reaction with eosinophilia and systemic symptoms) | Not known |
Dry skin | Common |
Dysguesia (taste perversion) (Taste abnormality) (Taste disturbance) | Uncommon |
Eczema | Common |
Eosinophilia | Rare |
Erythema multiforme | Very rare |
Gamma-GT increased | Common |
Headache | Common |
Hepatic failure (Hepatic insufficiency) (Liver failure) | Very rare |
Hepatic necrosis | Very rare |
Hepatitis | Rare |
Hyperlipidaemia | Uncommon |
Hypokalaemia | Uncommon |
Hypophosphataemia | Uncommon |
Hypouricaemia | Not known |
Infection | Rare |
Interstitial pneumonitis | Rare |
Jaundice | Rare |
Leucopenia (Leukopenia) | Not known |
Liver injury | Very rare |
Lyell Syndrome (Toxic epidermal necrolysis) | Very rare |
Lymphoproliferative disorder | Not known |
Maculopapular rash | Common |
Mouth ulceration | Common |
Nausea | Common |
Necrotizing vasculitis | Very rare |
Neoplasm malignant | Not known |
Neuropathy peripheral | Common |
Opportunistic infections | Not known |
Oral mucosal disorder | Common |
Pancreatitis | Very rare |
Pancytopenia | Rare |
Paraesthesia (paresthesia) | Common |
Pneumonia | Not known |
Pruritus | Common |
Psoriasis aggravated (Psoriasis flare-up) | Not known |
Pustular psoriasis | Not known |
Renal failure | Not known |
Rhinitis | Not known |
Sepsis (Systemic infection) (Sepsis state) | Rare |
Skin rash | Common |
Sperm concentration decreased | Not known |
Sperm count decreased | Not known |
Spermatozoa progressive motility decreased | Not known |
Stevens-Johnson syndrome | Very rare |
Tendon rupture | Uncommon |
Tenosynovitis | Common |
Thrombocytopenia (Thrombopenia) | Uncommon |
Transaminases increased | Common |
Urticaria | Uncommon |
Vasculitis | Very rare |
Vomiting | Common |
Weight decreased (Weight loss) | Common |
Arava 100mg* :
NB : Products With Same Indication |
Different Units By MoH Code
Arava 100mg* MoH 2158 :
Form | Tablet, Coated |
Packaging | Blisters |
Package Size | Box of 3 |
Strength | 100mg |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 405420/00 |
Submission date | 01/01/2000 |
Registration Year | 2000 |
Archived Date | 2017 |
Price Comparison
● Country: | Qatar | |
● Package Size: | 3 | |
● Public Price: | 214 QAR | ( 5,255,412.00 LBP ) |
● Pack size unit used: | 3 | |
● Cost/Unit: | 71,3333 QAR | ( 1,743,618.00 LBP ) |
● Pharmacy Price: | 175.21106382 QAR | ( 4302833.3052916 LBP ) |
● Pricing Date: | 28/01/2021 | |
● Type: | Medicine Authorised |
● Country: | UAE | |
● Package Size: | 3's Blister | |
● Public Price: | 211 AED | ( 5,097,971.00 LBP ) |
● Pack size unit used: | 3 | |
● Cost/Unit: | 70,3333 AED | ( 1,691,270.00 LBP ) |
● Pharmacy Price: | 169.79 AED | ( 4102296.19 LBP ) |
● Pricing Date: | 21/08/2019 | |
● Type: | Medicine Authorised |
● Country: | Abu Dhabi | |
● Package Size: | 3 | |
● Public Price: | 211 AED | ( 5,097,971.00 LBP ) |
● Pack size unit used: | 3 | |
● Cost/Unit: | 70,3333 AED | ( 1,691,270.00 LBP ) |
● Pharmacy Price: | 169.79 AED | ( 4102296.19 LBP ) |
● Pricing Date: | 27/01/2021 | |
● Type: | Medicine Authorised |
● Country: | The Netherlands | |
● Package Size: | 3 | |
● Public Price: | 43.08 EUR | ( 4,173,418.08 LBP ) |
● Pack size unit used: | 3 | |
● Cost/Unit: | 14,36 EUR | ( 1,356,264.00 LBP ) |
● Pharmacy Price: | 36.08 EUR | ( 3495286.08 LBP ) |
● Reference: | Zorginstituut Nederland | |
● Pricing Date: | 15/06/2019 | |
● Type: | Medicine Authorised |
● Country: | France | |
● Package Size: | 3 | |
● Public Price: | 39.56 EUR | ( 3,832,414.56 LBP ) |
● Pack size unit used: | 3 | |
● Cost/Unit: | 13,1867 EUR | ( 1,259,388.00 LBP ) |
● Reference: | ansm | |
● Pricing Date: | 15/05/2021 | |
● Type: | Medicine Authorised |
● Country: | Cyprus | |
● Package Size: | 3 TABS | |
● Public Price: | 40.07 EUR | ( 3,881,821.32 LBP ) |
● Pack size unit used: | 3 | |
● Cost/Unit: | 13,3567 EUR | ( 1,259,388.00 LBP ) |
● Reference: | Cyprus Minister of Health | |
● Pricing Date: | 24/03/2021 | |
● Type: | Medicine Authorised |
● Country: | UK | |
● Package Size: | 3 | |
● Public Price: | 30.67 GBP | ( 3,485,614.83 LBP ) |
● Pack size unit used: | 3 | |
● Cost/Unit: | 10,2233 GBP | ( 1,136,490.00 LBP ) |
● Reference: | DMD | |
● Pricing Date: | 08/03/2021 | |
● Type: | Medicine Withdrawn |
● Country: | Ireland | |
● Package Size: | 3 | |
● Public Price: | 33.21 EUR | ( 3,217,251.96 LBP ) |
● Pack size unit used: | 3 | |
● Cost/Unit: | 11,07 EUR | ( 1,065,636.00 LBP ) |
● Exfactory Price: | 31 EUR | |
● Pricing Date: | 09/10/2020 | |
● Type: | Medicine Authorised |
● Country: | Norway | |
● Package Size: | 3 | |
● Public Price: | 363.3 NOK | ( 2,944,183.20 LBP ) |
● Pack size unit used: | 3 | |
● Cost/Unit: | 121,1 NOK | ( 980,584.00 LBP ) |
● Pharmacy Price: | 256.51 NOK | ( 2078757.04 LBP ) |
● Reference: | Norwegian Medicine Agency | |
● Pricing Date: | 01/04/2020 | |
● Type: | Medicine Withdrawn |
● Country: | Italy | |
● Package Size: | 3 | |
● Public Price: | 32.51 EUR | ( 3,149,438.76 LBP ) |
● Pack size unit used: | 3 | |
● Cost/Unit: | 10,8367 EUR | ( 968,760.00 LBP ) |
● Pricing Date: | 17/12/2019 | |
● Type: | Medicine Authorised |
● Country: | Switzerland | |
● Package Size: | 3 | |
● Public Price: | 28.2 CHF | ( 2,916,444.00 LBP ) |
● Pack size unit used: | 3 | |
● Cost/Unit: | 9,4 CHF | ( 930,780.00 LBP ) |
● Exfactory Price: | 13.84 CHF | |
● Pricing Date: | 04/04/2021 | |
● Type: | Medicine Authorised |
● Country: | Spain | |
● Package Size: | 3 | |
● Public Price: | 26.96 EUR | ( 2,611,776.96 LBP ) |
● Pack size unit used: | 3 | |
● Cost/Unit: | 8,9867 EUR | ( 775,008.00 LBP ) |
● Medica Comments: | Non Marketed | |
● Reference: | Agencia Española de Medicamentos y Productos Sanitarios | |
● Pricing Date: | 06/05/2021 | |
● Type: | Medicine Non Marketed |
● Country: | Turkey | |
● Package Size: | 3 | |
● Public Price: | 69.25 TRY | ( 185,590.00 LBP ) |
● Pack size unit used: | 3 | |
● Cost/Unit: | 23,0833 TRY | ( 61,640.00 LBP ) |
● Pricing Date: | 28/10/2020 | |
● Type: | Medicine Authorised |
● Country: | Germany |
● Package Size: | 3 |
● Medica Comments: | Not available in the country of origin |
● Pricing Date: | 24/10/2020 |
● Type: | Medicine Non Marketed |
Note
You have to register to view this info
Drop File